Acute Myeloid Leukemia, Relapsed, Adult
6 clinical trials · Condition
◉ Watch Acute Myeloid Leukemia, Relapsed, Adult
| Record | Firm | Date |
|---|---|---|
| Natural Killer-cell Therapy for Acute Myeloid Leukemia (NCT04347616) | Radboud University Medical Center | 2020-12-03 |
| CLAG-GO for Patients With Persistent, Relapsed or Refractory AML (NCT04050280) | University of Maryland, Baltimore | 2019-11-01 |
| CDIAG Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (NCT03985007) | The First Affiliated Hospital of Soochow University | 2018-01-01 |
| Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia (NCT03063203) | Washington University School of Medicine | 2017-07-14 |
Track Acute Myeloid Leukemia, Relapsed, Adult automatically
Every clearance here is in the API, with alerts when new ones post.